Calcium Channel α2δ1 is Essential for Pancreatic Tumor-Initiating Cells through Sequential Phosphorylation of PKM2

被引:3
作者
Liu, Jingtao [1 ,2 ]
Tao, Ming [3 ]
Zhao, Wei [1 ]
Song, Qingru [1 ]
Yang, Xiaodan [1 ]
Li, Meng [1 ]
Zhang, Yanhua [2 ,5 ]
Xiu, Dianrong [3 ]
Zhang, Zhiqian [1 ,4 ]
机构
[1] Peking Univ Canc Hosp & Inst, Dept Cell Biol, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing, Peoples R China
[2] Peking Univ Canc Hosp & Inst, Dept Pharmacol, Beijing, Peoples R China
[3] Peking Univ Third Hosp, Dept Gen Surg, Beijing, Peoples R China
[4] Peking Univ Canc Hosp, 52 Fucheng Rd, Beijing 100142, Peoples R China
[5] Peking Univ Canc Hosp, Dept Pharmacol, Beijing, Peoples R China
来源
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 15卷 / 02期
基金
中国国家自然科学基金;
关键词
Pancreatic Cancer; Tumor-Initiating Cell; Therapeutic Target; CANCER STEM-CELLS; PYRUVATE-KINASE M2; PROMOTES; CAMKII; POPULATIONS; REGULATOR; BINDING; CA2+;
D O I
10.1016/j.jcmgh.2022.10.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Tumor-initiating cells (TICs) drive pancreatic cancer tumorigenesis, therapeutic resistance, and metastasis. However, TICs are highly plastic and heterogenous, which impede the robust identification and targeted therapy of such a population. The aim of this study is to identify the surface marker and therapeutic target for pancreatic TICs. METHODS: We isolated voltage-gated calcium channel alpha 2 delta 1 subunit (isoform 5)-positive subpopulation from pancreatic cancer cell lines and freshly resected primary tissues by fluorescence-activated cell sorting and evaluated their TIC properties by spheroid formation and tumorigenic assays. Coimmunoprecipitation was used to identify the direct substrate of CaMKIId. RESULTS: We demonstrate that the voltage-gated calcium channel alpha 2 delta 1 subunit (isoform 5) marks a subpopulation of pancreatic TICs with the highest TIC frequency among the known pancreatic TIC markers tested. Furthermore, alpha 2 delta 1 is functionally sufficient and indispensable to promote TIC properties by mediating Ca2+ influx, which activates CaMKIId to directly phosphorylate PKM2 at T454 that results in subsequent phosphorylation at Y105 to translocate into nucleus, enhancing the stem-like properties. Interestingly, blocking alpha 2 delta 1 with its specific antibody has remarkably therapeutic effects on pancreatic cancer xenografts by reducing TICs. CONCLUSIONS: alpha 2 delta 1 promotes pancreatic TIC properties through sequential phosphorylation of PKM2 mediated by CaMKIId, and targeting alpha 2 delta 1 provides a therapeutic strategy against TICs for pancreatic cancer.
引用
收藏
页码:373 / 392
页数:20
相关论文
共 50 条
  • [21] NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma
    Xiao, Zhi-Jie
    Liu, Jing
    Wang, Si-Qi
    Zhu, Yun
    Gao, Xu-Yuan
    Tin, Vicky Pui-Chi
    Qin, Jing
    Wang, Jun-Wen
    Wong, Maria Pik
    ELIFE, 2017, 6
  • [22] ULK1-dependent phosphorylation of PKM2 antagonizes O-GlcNAcylation and regulates the Warburg effect in breast cancer
    Zhou, Zibin
    Zheng, Xiyuan
    Zhao, Jianxin
    Yuan, Aiyun
    Lv, Zhuan
    Shao, Guangcan
    Peng, Bin
    Dong, Meng-Qiu
    Xu, Quan
    Xu, Xingzhi
    Li, Jing
    ONCOGENE, 2024, 43 (23) : 1769 - 1778
  • [23] Cyclin G1 Expands Liver Tumor-Initiating Cells by Sox2 Induction via Akt/mTOR Signaling
    Wen, Wen
    Han, Tao
    Huang, Lei
    Sun, Wen
    Wang, Xue
    Chen, Shu-Zhen
    Xiang, Dai-Min
    Tang, Liang
    Cao, Dan
    Feng, Gen-Sheng
    Wu, Meng-Chao
    Ding, Jin
    Wang, Hong-Yang
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (09) : 1796 - 1804
  • [24] ABCG2-Meditated Multidrug Resistance and Tumor-Initiating Capacity of Side Population Cells from Colon Cancer
    Xie, Zheng-Yuan
    Lv, Ke
    Xiong, Ying
    Guo, Wu-Hua
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (11) : 666 - 672
  • [25] Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer
    M Kondratyev
    A Kreso
    R M Hallett
    A Girgis-Gabardo
    M E Barcelon
    D Ilieva
    C Ware
    P K Majumder
    J A Hassell
    Oncogene, 2012, 31 : 93 - 103
  • [26] Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer
    Kondratyev, M.
    Kreso, A.
    Hallett, R. M.
    Girgis-Gabardo, A.
    Barcelon, M. E.
    Ilieva, D.
    Ware, C.
    Majumder, P. K.
    Hassell, J. A.
    ONCOGENE, 2012, 31 (01) : 93 - 103
  • [27] BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation
    Lin Wang
    Paul Park
    Frank La Marca
    Khoi D. Than
    Chia-Ying Lin
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 1013 - 1024
  • [28] BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation
    Wang, Lin
    Park, Paul
    La Marca, Frank
    Than, Khoi D.
    Lin, Chia-Ying
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (06) : 1013 - 1024
  • [29] Muscle-specific pyruvate kinase isoforms, PKM1 and PKM2, regulate mammalian SWI/SNF proteins and histone 3 phosphorylation during myoblast differentiation
    Olea-Flores, Monserrat
    Sharma, Tapan
    Verdejo-Torres, Odette
    DiBartolomeo, Imaru
    Thompson, Paul R.
    Padilla-Benavides, Teresita
    Imbalzano, Anthony N.
    FASEB JOURNAL, 2024, 38 (11)
  • [30] E2A attenuates tumor-initiating capacity of colorectal cancer cells via the Wnt/beta-catenin pathway
    Zhao, Hongchao
    Zhao, Chunlin
    Li, Haohao
    Zhang, Danhua
    Liu, Guanghui
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)